Factors affecting response of chemotherapy in women with ovarian cancer

被引：0
|
作者：
Lubin, J. [1 ]
Markowska, A. [2 ]
Knapp, P. [3 ]
机构：
[1] Clin Oncol Poznan, Dept Gynecol, Poznan, Poland
[2] Inst Gynecol & Obstet, Poznan, Poland
[3] Univ Hosp Bialystok, Dept Gynecol, Bialystok, Poland
来源：
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | 2012年 / 33卷 / 06期
关键词：
Ovarian cancer; Chemotherapy; Factors affecting chemotherapy; MULTIDRUG-RESISTANCE GENE; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PRODUCT P-GLYCOPROTEIN; PACLITAXEL RESISTANCE; PROTEIN LRP; E-CADHERIN; EXPRESSION; CLUSTERIN; MDR1; CYCLOOXYGENASE-2;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Chemotherapy plays an important role in the treatment of ovarian cancer. Patients' response to chemotherapy is determined by a variety of acknowledged factors, but one might expect that many of them are yet to be described. The aim of this paper was to present the most essential yet still to be generally assessed in clinical practice, factors, which include: E-cadhedrin, hypoxia inducible factor alpha, survivin, COX-2, clusterin, BRCA1 protein, TP53 protein, YY1 protein, multidrug resistance protein, and interleukin-8.
引用
收藏
页码：644 / 647
页数：4
相关论文
共 50 条
  • [21] Intraperitoneal chemotherapy in older women with epithelial ovarian cancer
    O'Cearbhaill, Roisin
    Li, Daneng
    Shi, Weiji
    Thaler, Howard
    Sabbatini, Paul J.
    Konner, Jason
    Hensley, Martee L.
    Aghajanian, Carol A.
    Lichtman, Stuart M.
    Tew, William P.
    JOURNAL OF GERIATRIC ONCOLOGY, 2012, 3 (03) : 189 - 195
  • [22] Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian Ovarian Cancer Study (AOCS)
    Au-Yeung, George
    Webb, Penelope M.
    DeFazio, Anna
    Fereday, Sian
    Bressel, Mathias
    Mileshkin, Linda
    GYNECOLOGIC ONCOLOGY, 2014, 133 (01) : 16 - 22
  • [23] Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer
    Naumann, R. Wendel
    Sukumvanich, Paniti
    Edwards, Robert P.
    GYNECOLOGIC ONCOLOGY, 2009, 114 (01) : 37 - 41
  • [24] Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer
    Lambrechts, Sandrina
    Lambrechts, Diether
    Despierre, Evelyn
    Van Nieuwenhuysen, Els
    Smeets, Dominiek
    Debruyne, Philip R.
    Renard, Vincent
    Vroman, Philippe
    Luyten, Daisy
    Neven, Patrick
    Amant, Frederic
    Leunen, Karin
    Vergote, Ignace
    BMC PHARMACOLOGY & TOXICOLOGY, 2015, 16
  • [25] Possible Prognostic Role of BMI Before Chemotherapy in the Outcomes of Women with Ovarian Cancer
    Paschou, Stavroula A.
    Andrikopoulou, Angeliki
    Mili, Nikoletta
    Svarna, Anna
    Kaparelou, Maria
    Stefanaki, Katerina
    Dedes, Nikolaos
    Liatsou, Efstathia
    Thomakos, Nikolaos
    Haidopoulos, Dimitrios
    Psaltopoulou, Theodora
    Kastritis, Efstathios
    Zagouri, Flora
    Dimopoulos, Meletios-Athanasios
    Liontos, Michalis
    NUTRIENTS, 2025, 17 (03)
  • [26] BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer
    Carser, Judith E.
    Quinn, Jennifer E.
    Michie, Caroline O.
    O'Brien, Eamonn J.
    McCluggage, W. Glenn
    Maxwell, Perry
    Lamers, Elisabeth
    Lioe, Tong F.
    Williams, Alistair R. W.
    Kennedy, Richard D.
    Gourley, Charlie
    Harkin, D. Paul
    GYNECOLOGIC ONCOLOGY, 2011, 123 (03) : 492 - 498
  • [27] Intraperitoneal chemotherapy in ovarian cancer
    Hofstra, LS
    de Vries, EGE
    Mulder, NH
    Willemse, PHB
    CANCER TREATMENT REVIEWS, 2000, 26 (02) : 133 - 143
  • [28] Individualization of ovarian cancer chemotherapy
    Yevtushenko, GV
    Vinnitskaya, AB
    Svintsitsky, VS
    Vorobyova, LI
    EXPERIMENTAL ONCOLOGY, 1997, 19 (02): : 167 - 169
  • [29] Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancer
    Sandrina Lambrechts
    Diether Lambrechts
    Evelyn Despierre
    Els Van Nieuwenhuysen
    Dominiek Smeets
    Philip R Debruyne
    Vincent Renard
    Philippe Vroman
    Daisy Luyten
    Patrick Neven
    Frédéric Amant
    Karin Leunen
    Ignace Vergote
    BMC Pharmacology and Toxicology, 16
  • [30] Chemotherapy in epithelial ovarian cancer
    Pignata, Sandro
    Cannella, Lucia
    Leopardo, Davide
    Pisano, Carmela
    Bruni, Giovanni Salvatore
    Facchini, Gaetano
    CANCER LETTERS, 2011, 303 (02) : 73 - 83
12345